LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease†

作者: Cyrus P. Zabetian , Mitsutoshi Yamamoto , Alexis N. Lopez , Hiroshi Ujike , Ignacio F. Mata

DOI: 10.1002/MDS.22514

关键词:

摘要: The study of large multigenerational pedigrees has yielded five genes that underlie autosomal dominant (SNCA, LRRK2) or recessive (PARK2 [parkin], PINK1, PARK7 [DJ-1]) forms Parkinson’s disease (PD).1 Of these genes, mutations in LRRK2 are the most prevalent patients with PD European origin.1 However, much less is known about spectrum and frequency other populations, including Asians. Furthermore, many reported, thus far, have not yet been shown to segregate assayed a number control subjects, uncertain pathogenicity. Addressing gaps knowledge important on both clinical grounds (e.g., genetic testing counseling) for understanding molecular mechanisms involved LRRK2-related PD. In addition alone sufficient cause disease, two common nonsynonymous single nucleotide polymorphisms (SNPs) within (G2385R R1628P), specific Asian reported associate risk.2,3 Given limited risk factors identified date, this represents potentially major finding. burden proof incumbent case-control association studies necessitates such findings be rigorously replicated multiple datasets. We conducted comprehensive screen coding region Japanese cohort familial examined putative pathogenic alleles sample. We also performed meta-analysis reporting data G2385R.

参考文章(37)
Eng-King Tan, Yi Zhao, Louis Tan, Hui-Qin Lim, Jasinda Lee, Yih Yuen, Ratnagopal Pavanni, Meng-Cheong Wong, Stephanie Fook-Chong, Jian-Jun Liu, Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians. Movement Disorders. ,vol. 22, pp. 1816- 1818 ,(2007) , 10.1002/MDS.21658
D. B. Calne, B. J. Snow, C. Lee, Criteria for diagnosing Parkinson's disease. Annals of Neurology. ,vol. 32, ,(1992) , 10.1002/ANA.410320721
Cyrus P. Zabetian, Carolyn M. Hutter, Stewart A. Factor, John G. Nutt, Donald S. Higgins, Alida Griffith, John W. Roberts, Berta C. Leis, Denise M. Kay, Dora Yearout, Jennifer S. Montimurro, Karen L. Edwards, Ali Samii, Haydeh Payami, Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease Annals of Neurology. ,vol. 62, pp. 137- 144 ,(2007) , 10.1002/ANA.21157
Eng-King Tan, Lisa M. Skipper, Pathogenic mutations in Parkinson disease Human Mutation. ,vol. 28, pp. 641- 653 ,(2007) , 10.1002/HUMU.20507
Suzanne Lesage, Alexandra Dürr, Meriem Tazir, Ebba Lohmann, Anne-Louise Leutenegger, Sabine Janin, Pierre Pollak, Alexis Brice, LRRK2 G2019S as a Cause of Parkinson's Disease in North African Arabs The New England Journal of Medicine. ,vol. 354, pp. 422- 423 ,(2006) , 10.1056/NEJMC055540
Manabu Funayama, Yuanzhe Li, Hiroyuki Tomiyama, Hiroyo Yoshino, Yoko Imamichi, Mitsutoshi Yamamoto, Miho Murata, Tatsushi Toda, Yoshikuni Mizuno, Nobutaka Hattori, leucine-rich Repeat kinase 2 G2385r variant is a risk factor for Parkinson disease in Asian population Neuroreport. ,vol. 18, pp. 273- 275 ,(2007) , 10.1097/WNR.0B013E32801254B6
Laurie J. Ozelius, Geetha Senthil, Rachel Saunders-Pullman, Erin Ohmann, Amanda Deligtisch, Michele Tagliati, Ann L. Hunt, Christine Klein, Brian Henick, Susan M. Hailpern, Richard B. Lipton, Jeannie Soto-Valencia, Neil Risch, Susan B. Bressman, LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. The New England Journal of Medicine. ,vol. 354, pp. 424- 425 ,(2006) , 10.1056/NEJMC055509
Nathan Pankratz, Tatiana Foroud, Genetics of Parkinson disease. Genetics in Medicine. ,vol. 9, pp. 801- 811 ,(2007) , 10.1097/GIM.0B013E31815BF97C